7-bromo-2-chloro-4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]thieno[3,2-d]pyrimidine;4-[7-bromo-4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]thieno[3,2-d]pyrimidin-2-yl]morpholine;7-bromo-2,4-dichlorothieno[3,2-d]pyrimidine;2-[1-[[4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperidin-4-yl]propan-2-ol;3-(cyclopropylsulfonylmethyl)-2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;morpholine
C91H107BBr3Cl3N16O18S8 — CID 159931227
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-bromo-2-chloro-4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]thieno[3,2-d]pyrimidine;4-[7-bromo-4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]thieno[3,2-d]pyrimidin-2-yl]morpholine;7-bromo-2,4-dichlorothieno[3,2-d]pyrimidine;2-[1-[[4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperidin-4-yl]propan-2-ol;3-(cyclopropylsulfonylmethyl)-2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;morpholine
7-bromo-2-chloro-4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]thieno[3,2-d]pyrimidine;4-[7-bromo-4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]thieno[3,2-d]pyrimidin-2-yl]morpholine;7-bromo-2,4-dichlorothieno[3,2-d]pyrimidine;2-[1-[[4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperidin-4-yl]propan-2-ol;3-(cyclopropylsulfonylmethyl)-2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;morpholine (PubChem CID 159931227) has the molecular formula C91H107BBr3Cl3N16O18S8 and a molecular weight of 2326.37 g/mol. Its IUPAC name is 7-bromo-2-chloro-4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]thieno[3,2-d]pyrimidine;4-[7-bromo-4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]thieno[3,2-d]pyrimidin-2-yl]morpholine;7-bromo-2,4-dichlorothieno[3,2-d]pyrimidine;2-[1-[[4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperidin-4-yl]propan-2-ol;3-(cyclopropylsulfonylmethyl)-2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;morpholine.
Molecular Properties
| Compound Name | 7-bromo-2-chloro-4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]thieno[3,2-d]pyrimidine;4-[7-bromo-4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]thieno[3,2-d]pyrimidin-2-yl]morpholine;7-bromo-2,4-dichlorothieno[3,2-d]pyrimidine;2-[1-[[4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperidin-4-yl]propan-2-ol;3-(cyclopropylsulfonylmethyl)-2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;morpholine |
|---|---|
| PubChem CID | 159931227 |
| Molecular Formula | C91H107BBr3Cl3N16O18S8 |
| Molecular Weight | 2326.37 g/mol |
| Exact Mass | 2320.24 |
| IUPAC Name | 7-bromo-2-chloro-4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]thieno[3,2-d]pyrimidine;4-[7-bromo-4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]thieno[3,2-d]pyrimidin-2-yl]morpholine;7-bromo-2,4-dichlorothieno[3,2-d]pyrimidine;2-[1-[[4-[5-(cyclopropylsulfonylmethyl)-6-methoxy-3-pyridinyl]-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperidin-4-yl]propan-2-ol;3-(cyclopropylsulfonylmethyl)-2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;morpholine |
| SMILES | C1COCCN1.COc1ncc(-c2nc(Cl)nc3c(Br)csc23)cc1CS(=O)(=O)C1CC1.COc1ncc(-c2nc(N3CCOCC3)nc3c(Br)csc23)cc1CS(=O)(=O)C1CC1.COc1ncc(-c2nc(N3CCOCC3)nc3c(CN4CCC(C(C)(C)O)CC4)csc23)cc1CS(=O)(=O)C1CC1.COc1ncc(B2OC(C)(C)C(C)(C)O2)cc1CS(=O)(=O)C1CC1.Clc1nc(Cl)c2scc(Br)c2n1 |
| InChI | InChI=1S/C29H39N5O5S2.C20H21BrN4O4S2.C16H24BNO5S.C16H13BrClN3O3S2.C6HBrCl2N2S.C4H9NO/c1-29(2,35)22-6-8-33(9-7-22)16-21-17-40-26-24(31-28(32-25(21)26)34-10-12-39-13-11-34)19-14-20(27(38-3)30-15-19)18-41(36,37)23-4-5-23;1-28-19-13(11-31(26,27)14-2-3-14)8-12(9-22-19)16-18-17(15(21)10-30-18)24-20(23-16)25-4-6-29-7-5-25;1-15(2)16(3,4)23-17(22-15)12-8-11(14(21-5)18-9-12)10-24(19,20)13-6-7-13;1-24-15-9(7-26(22,23)10-2-3-10)4-8(5-19-15)12-14-13(11(17)6-25-14)21-16(18)20-12;7-2-1-12-4-3(2)10-6(9)11-5(4)8;1-3-6-4-2-5-1/h14-15,17,22-23,35H,4-13,16,18H2,1-3H3;8-10,14H,2-7,11H2,1H3;8-9,13H,6-7,10H2,1-5H3;4-6,10H,2-3,7H2,1H3;1H;5H,1-4H2 |
| InChIKey | NZQVWEGIIJUGRI-UHFFFAOYSA-N |
| XLogP | 16.19 |
| TPSA | 416.29 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 140 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2326.37 |
| LogP ≤ 5 | 16.19 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 38 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159931227 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.